HIV-1, ubiquitin and ubiquitin-like proteins: The dialectic interactions of a virus with a sophisticated network of post-translational modifications

Biology of the Cell

Volumn 104, Issue 3, 2012, Pages 165-187

  Biard Piechaczyk, Martine ^a   Borel, Sophie ^a   Espert, Lucile ^a   de Bettignies, Geoffroy ^b   Coux, Olivier ^b  

^a Centre détude dagents Pathogènes et Biotechnologies pour la Santé CPBS CNRS   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

HIV; Ubiquitin; Ubiquitin like protein

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 1; NEDD8 PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN; VIRUS DNA; VIRUS PROTEIN;

AUTOPHAGY; CELL MEMBRANE; CELL VACUOLE; COMPLEX FORMATION; CONJUGATION; DNA TRANSCRIPTION; GENETIC TRANSCRIPTION; GENOME; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RETROVIRUS; REVIEW; VIRUS; VIRUS ENTRY; VIRUS RELEASE;

CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN; UBIQUITINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84861369218     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1111/boc.201100112     Document Type: Review

References (211)

1. Afonso, P.V., Zamborlini, A., Saïb, A. and Mahieux, R. (2007) Centrosome and retroviruses: The dangerous liaisons. Retrovirology 4, 27.
2. Ahn, J., Vu, T., Novince, Z., Guerrero-Santoro, J., Rapic-Otrin, V. and Gronenborn, A.M. (2010) HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation. J. Biol. Chem. 285, 37333-37341.
3. Aichem, A., Pelzer, C., Lukasiak, S., Kalveram, B., Sheppard, P.W., Rani, N., Schmidtke, G. and Groettrup, M. (2010) USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat. Commun. 1, 1-10.
4. Alroy, I., Tuvia, S., Greener, T., Gordon, D., Barr, H.M., Taglicht, D., Mandil-Levin, R., Ben-Avraham, D., Konforty, D., Nir, A., Levius, O., Bicoviski, V., Dori, M., Cohen, S., Yaar, L., Erez, O., Propheta-Meiran, O., Koskas, M., Caspi-Bachar, E., Alchanati, I., Sela-Brown, A., Moskowitz, H., Tessmer, U., Schubert, U. and Reiss, Y. (2005) The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production. Proc. Natl. Acad. Sci. U.S.A 102, 1478-1483.
5. Apcher, G.S., Heink, S., Zantopf, D., Kloetzel, P.-M., Schmid, H.-P., Mayer, R.J. and Krüger, E. (2003) Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett. 553, 200-204.
6. Arriagada, G., Muntean, L.N. and Goff, S.P. (2011) SUMO-interacting motifs of human TRIM5α are important for antiviral activity. PLoS Pathog. 7, e1002019.
7. Barboric, M., Zhang, F., Besenicar, M., Plemenitas, A. and Peterlin, B.M. (2005) Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation. J. Virol. 79, 11135-11141.
8. Barraud, P., Paillart, J.-C., Marquet, R. and Tisné, C. (2008) Advances in the structural understanding of Vif proteins. Curr. HIV Res 6, 91-99.
9. Bedford, L., Lowe, J., Dick, L.R., Mayer, R.J. and Brownell, J.E. (2011) Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat. Rev. Drug Discov. 10, 29-46.
10. Bedford, L., Paine, S., Sheppard, P.W., Mayer, R.J. and Roelofs, J. (2010) Assembly, structure, and function of the 26S proteasome. Trends Cell Biol. 20, 391-401.
11. Belzile, J.-P., Abrahamyan, L.G., Gérard, F.C.A., Rougeau, N. and Cohen, E.A. (2010a) Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest. PLoS Pathog. 6, e1001080.
12. Belzile, J.-P., Richard, J., Rougeau, N., Xiao, Y. and Cohen, E.A. (2010b) HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest. J. Virol. 84, 3320-3330.
13. Besnard-Guerin, C., Belaïdouni, N., Lassot, I., Segeral, E., Jobart, A., Marchal, C. and Benarous, R. (2004) HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. J. Biol. Chem. 279, 788-795.
14. Binette, J., Dubé, M., Mercier, J., Halawani, D., Latterich, M. and Cohen, E.A. (2007) Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4, 75.
15. Black, L.R. and Aiken, C. (2010) TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J. Virol. 84, 6564-6569.
16. Blanchet, F.P., Moris, A., Nikolic, D.S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., Schwartz, O., Deretic, V. and Piguet, V. (2010) Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 32, 654-669.
17. Boggio, R. and Chiocca, S. (2005) Gam1 and the SUMO pathway. Cell Cycle 4, 533-535.
18. Bour, S., Perrin, C., Akari, H. and Strebel, K. (2001) The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276, 15920-15928.
19. Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J., Lieberman, J. and Elledge, S.J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926.
20. Breiner, K.M., Urban, S., Glass, B. and Schaller, H. (2001) Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes. J. Virol. 75, 143-150.
21. Brès, V., Kiernan, R.E., Linares, L.K., Chable-Bessia, C., Plechakova, O., Tréand, C., Emiliani, S., Peloponese, J.-M., Jeang, K.-T., Coux, O., Scheffner, M. and Benkirane, M. (2003) A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat. Cell Biol. 5, 754-761.
22. Campbell, S. and Vogt, V.M. (1995) Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69, 6487-6497.
23. Casey, L., Wen, X. and de Noronha, C.M.C. (2010) The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase. Cytokine 51, 1-9.
24. Chen, Z.J. and Sun, L.J. (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33, 275-86.
25. Chu, Y. and Yang, X. (2011) SUMO E3 ligase activity of TRIM proteins. Oncogene 30, 1108-1116.
26. Cochrane, A.W., McNally, M.T. and Mouland, A.J. (2006) The retrovirus RNA trafficking granule: From birth to maturity. Retrovirology 3, 18.
27. Col, E., Caron, C., Chable-Bessia, C., Legube, G., Gazzeri, S., Komatsu, Y., Yoshida, M., Benkirane, M., Trouche, D. and Khochbin, S. (2005) HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J 24, 2634-2645.
28. Collins, G.A. and Tansey, W.P. (2006) The proteasome: A utility tool for transcription? Curr. Opin. Genet. Dev. 16, 197-202.
29. Dang, Y., Siew, L.M. and Zheng, Y.-H. (2008) APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated. J. Biol. Chem. 283, 13124-13131.
30. daSilva, L.L.P., Sougrat, R., Burgos, P.V., Janvier, K., Mattera, R. and Bonifacino, J.S. (2009) Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. J. Virol. 83, 6578-6590.
31. Dastur, A., Beaudenon, S., Kelley, M., Krug, R.M. and Huibregtse, J.M. (2006) Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281, 4334-4338.
32. DeHart, J.L., Bosque, A., Harris, R.S. and Planelles, V. (2008) Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J. Virol. 82, 9265-9272.
33. DeHart, J.L., Zimmerman, E.S., Ardon, O., Monteiro-Filho, C.M.R., Argañaraz, E.R. and Planelles, V. (2007) HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. J. Virol. 4, 57.
34. Delwart, E.L. and Panganiban, A.T. (1989) Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J. Virol 63, 273-280.
35. Demartino, G.N. and Gillette, T.G. (2007) Proteasomes: Machines for all reasons. Cell 129, 659-662.
36. Deneka, M., Pelchen-Matthews, A., Byland, R., Ruiz-Mateos, E. and Marsh, M. (2007) In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177, 329-341.
37. Denizot, M., Varbanov, M., Espert, L., Robert-Hebmann, V., Sagnier, S., Garcia, E., Curriu, M., Mamoun, R., Blanco, J. and Biard-Piechaczyk, M. (2008) HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 4, 998-1008.
38. Deshaies, R.J. and Joazeiro, C.A.P. (2009) RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434.
39. Dikic, I., Wakatsuki, S. and Walters, K.J. (2009) Ubiquitin-binding domains-From structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659-671.
40. Ding, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D.B., Ron, D. and Yin, X.-M. (2007) Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171, 513-524.
41. Douglas, J.L., Viswanathan, K., McCarroll, M.N., Gustin, J.K., Früh, K. and Moses, A.V. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J. Virol. 83, 7931-7947.
42. Dubiel, W., Ferrell, K. and Rechsteiner, M. (1994) Tat-binding protein 7 is a subunit of the 26S protease. Biol. Chem. Hoppe-Seyler 375, 237-240.
43. Durfee, L.A., Kelley, M.L. and Huibregtse, J.M. (2008) The basis for selective E1-E2 interactions in the ISG15 conjugation system. J. Biol. Chem. 283, 23895-23902.
44. Durfee, L.A., Lyon, N., Seo, K. and Huibregtse, J.M. (2010) The ISG15 conjugation system broadly targets newly synthesized proteins: Implications for the antiviral function of ISG15. Mol. Cell 38, 722-732.
45. Dussart, S., Courcoul, M., Bessou, G., Douaisi, M., Duverger, Y., Vigne, R. and Decroly, E. (2004) The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin. Biochem. Biophys. Res. Commun. 315, 66-72.
46. English, L., Chemali, M. and Desjardins, M. (2009) Nuclear membrane-derived autophagy, a novel process that participates in the presentation of endogenous viral antigens during HSV-1 infection. Autophagy 5, 1026-1029.
47. Espert, L., Codogno, P. and Biard-Piechaczyk, M. (2007) Involvement of autophagy in viral infections: Antiviral function and subversion by viruses. J. Mol. Med. 85, 811-823.
48. Espert, L., Denizot, M., Grimaldi, M., Robert-Hebmann, V., Gay, B., Varbanov, M., Codogno, P. and Biard-Piechaczyk, M. (2006) Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 116, 2161-2172.
49. Espert, L., Varbanov, M., Robert-Hebmann, V., Sagnier, S., Robbins, I., Sanchez, F., Lafont, V. and Biard-Piechaczyk, M. (2009) Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 4, e5787.
50. Esposito, V., Manente, L., Perna, A., Gargiulo, M., Viglietti, R., Sangiovanni, V., Doula, N., Liuzzi, G., Baldi, A., De Luca, A. and Chirianni, A. (2009) Role of NEDD8 in HIV-associated lipodystrophy. Differentiation 77, 148-153.
51. Estrabaud, E., Le Rouzic, E., Lopez-Vergès, S., Morel, M., Belaïdouni, N., Benarous, R., Transy, C., Berlioz-Torrent, C. and Margottin-Goguet, F. (2007) Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles. PLoS Pathog. 3, e104.
52. Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C. and Li, P. (2004) Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif. J. Virol. 78, 10574-10581.
53. Freed, E.O. (1998) HIV-1 gag proteins: Diverse functions in the virus life cycle. Virology 251, 1-15.
54. Gallastegui, N. and Groll, M. (2010) The 26S proteasome: Assembly and function of a destructive machine. Trends Biochem. Sci. 35, 634-42.
55. Gareau, J.R. and Lima, C.D. (2010) The SUMO pathway: Emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871.
56. Gargano, B., Fiorillo, M., Amente, S., Majello, B. and Lania, L. (2008) p14ARF is capable of promoting HIV-1 tat degradation. Cell Cycle 7, 1433-1439.
57. Garrus, J.E., von Schwedler, U.K., Pornillos, O.W., Morham, S.G., Zavitz, K.H., Wang, H.E., Wettstein, D.A., Stray, K.M., Côté, M., Rich, R.L., Myszka, D.G. and Sundquist, W.I. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65.
58. Gautheron, J. and Courtois, G. (2010) Without Ub I am nothing: NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation. Cell. Mol. Life Sci. 67, 3101-3113.
59. Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D. and De Wilde, M. (1989) Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
60. Goffinet, C., Allespach, I., Homann, S., Tervo, H.-M., Habermann, A., Rupp, D., Oberbremer, L., Kern, C., Tibroni, N., Welsch, S., Krijnse-Locker, J., Banting, G., Kräusslich, H.-G., Fackler, O.T. and Keppler, O.T. (2009) HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5, 285-297.
61. Goila-Gaur, R. and Strebel, K. (2008) HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 51.
62. Gorry, P.R. and Ancuta, P. (2011) Coreceptors and HIV-1 pathogenesis. Curr HIV/AIDS Rep 8, 45-53.
63. Gottwein, E. and Kräusslich, H.-G. (2005) Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J. Virol. 79, 9134-9144.
64. Greene, W.C. (1990) Regulation of HIV-1 gene expression. Annu. Rev. Immunol. 8, 453-475.
65. Grossman, S.R., Deato, M.E., Brignone, C., Chan, H.M., Kung, A.L., Tagami, H., Nakatani, Y. and Livingston, D.M. (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342-344.
66. Gurer, C., Berthoux, L. and Luban, J. (2005) Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J. Virol. 79, 910-917.
67. Habermann, A., Krijnse-Locker, J., Oberwinkler, H., Eckhardt, M., Homann, S., Andrew, A., Strebel, K. and Kräusslich, H.-G. (2010) CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J. Virol. 84, 4646-4658.
68. Hanada, T., Noda, N.N., Satomi, Y., Ichimura, Y., Fujioka, Y., Takao, T., Inagaki, F. and Ohsumi, Y. (2007) The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J. Biol. Chem. 282, 37298-37302.
69. Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H. and Mizushima, N. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889.
70. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D.O. and Landau, N.R. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705-6711.
71. Hipp, M.S., Kalveram, B., Raasi, S., Groettrup, M. and Schmidtke, G. (2005) FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 25, 3483-3491.
72. Hochstrasser, M. (2009) Origin and function of ubiquitin-like proteins. Nature 458, 422-429.
73. Huang, D.T., Ayrault, O., Hunt, H.W., Taherbhoy, A.M., Duda, D.M., Scott, D.C., Borg, L.A., Neale, G., Murray, P.J., Roussel, M.F. and Schulman, B.A. (2009) E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33, 483-495.
74. Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., Mizushima, N., Tanida, I., Kominami, E., Ohsumi, M., Noda, T. and Ohsumi, Y. (2000) A ubiquitin-like system mediates protein lipidation. Nature 408, 488-492.
75. Ikeda, F., Crosetto, N. and Dikic, I. (2010) What determines the specificity and outcomes of ubiquitin signaling? Cell 143, 677-681.
76. Iordanskiy, S., Berro, R., Altieri, M., Kashanchi, F. and Bukrinsky, M. (2006) Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 3, 4.
77. Iwabu, Y., Fujita, H., Kinomoto, M., Kaneko, K., Ishizaka, Y., Tanaka, Y., Sata, T. and Tokunaga, K. (2009) HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284, 35060-35072.
78. Iwata, A., Riley, B.E., Johnston, J.A. and Kopito, R.R. (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J. Biol. Chem. 280, 40282-40292.
79. Iwatani, Y., Chan, D.S.B., Liu, L., Yoshii, H., Shibata, J., Yamamoto, N., Levin, J.G., Gronenborn, A.M. and Sugiura, W. (2009) HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain. Proc. Natl. Acad. Sci. U.S.A 106, 19539-19544.
80. Izumi, T., Io, K., Matsui, M., Shirakawa, K., Shinohara, M., Nagai, Y., Kawahara, M., Kobayashi, M., Kondoh, H., Misawa, N., Koyanagi, Y., Uchiyama, T. and Takaori-Kondo, A. (2010) HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc. Natl. Acad. Sci. U.S.A 107, 20798-20803.
81. Izumi, T., Takaori-Kondo, A., Shirakawa, K., Higashitsuji, H., Itoh, K., Io, K., Matsui, M., Iwai, K., Kondoh, H., Sato, T., Tomonaga, M., Ikeda, S., Akari, H., Koyanagi, Y., Fujita, J. and Uchiyama, T. (2009) MDM2 is a novel E3 ligase for HIV-1 Vif. Retrovirology 6, 1.
82. Jaber, T., Bohl, C.R., Lewis, G.L., Wood, C., West, J.T., Jr and Weldon, R.A., Jr (2009) Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions. J. Virol. 83, 10448-10459.
83. Jäger, S., Gottwein, E. and Kräusslich, H.-G. (2007) Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J. Virol. 81, 9193-9201.
84. Javanbakht, H., Diaz-Griffero, F., Stremlau, M., Si, Z. and Sodroski, J. (2005) The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J. Biol. Chem 280, 26933-26940.
85. Jin, Y.-J., Cai, C.Y., Zhang, X. and Burakoff, S.J. (2008) Lysine 144, a ubiquitin attachment site in HIV-1 Nef, is required for Nef-mediated CD4 down-regulation. J. Immunol 180, 7878-7886.
86. Jouve, M., Sol-Foulon, N., Watson, S., Schwartz, O. and Benaroch, P. (2007) HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe 2, 85-95.
87. Jowett, J.B., Planelles, V., Poon, B., Shah, N.P., Chen, M.L. and Chen, I.S. (1995) The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
88. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y. and Yoshimori, T. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720-5728.
89. Kalantari, P., Harandi, O.F., Hankey, P.A. and Henderson, A.J. (2008) HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation. J. Immunol. 181, 1548-1555.
90. Kiernan, R.E., Emiliani, S., Nakayama, K., Castro, A., Labbé, J.C., Lorca, T., Nakayama Ki, K. and Benkirane, M. (2001) Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol. 21, 7956-7970.
91. Kiernan, R.E., Vanhulle, C., Schiltz, L., Adam, E., Xiao, H., Maudoux, F., Calomme, C., Burny, A., Nakatani, Y., Jeang, K.T., Benkirane, M. and Van Lint, C. (1999) HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18, 6106-6118.
92. Kim, M.-J. and Yoo, J.-Y. (2010) Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J. Immunol. 185, 4311-4318.
93. Komatsu, M., Kominami, E. and Tanaka, K. (2006) Autophagy and neurodegeneration. Autophagy 2, 315-317.
94. König, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M.C., Irelan, J.T., Chiang, C.-Y., Tu, B.P., De Jesus, P.D., Lilley, C.E., Seidel, S., Opaluch, A.M., Caldwell, J.S., Weitzman, M.D., Kuhen, K.L., Bandyopadhyay, S., Ideker, T., Orth, A.P., Miraglia, L.J., Bushman, F.D., Young, J.A. and Chanda, S.K. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60.
95. Korolchuk, V.I., Menzies, F.M. and Rubinsztein, D.C. (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 584, 1393-1398.
96. Kuhl, B.D., Cheng, V., Wainberg, M.A. and Liang, C. (2011) Tetherin and its viral antagonists. J Neuroimmune Pharmacol. 6, 188-201.
97. Kyei, G.B., Dinkins, C., Davis, A.S., Roberts, E., Singh, S.B., Dong, C., Wu, L., Kominami, E., Ueno, T., Yamamoto, A., Federico, M., Panganiban, A., Vergne, I. and Deretic, V. (2009) Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186, 255-268.
98. Laguette, N., Brégnard, C., Benichou, S. and Basmaciogullari, S. (2010) Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol. Aspects Med. 31, 418-433.
99. Langelier, C., von Schwedler, U.K., Fisher, R.D., De Domenico, I., White, P.L., Hill, C.P., Kaplan, J., Ward, D. and Sundquist, W.I. (2006) Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J. Virol. 80, 9465-9480.
100. Lassot, I., Latreille, D., Rousset, E., Sourisseau, M., Linares, L.K., Chable-Bessia, C., Coux, O., Benkirane, M. and Kiernan, R.E. (2007) The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol. Cell 25, 369-83.
101. Le Tortorec, A. and Neil, S.J.D. (2009) Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83, 11966-11978.
102. Levine, B. and Deretic, V. (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7, 767-777.
103. Levine, B. and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42.
104. Li, L., Li, H.S., Pauza, C.D., Bukrinsky, M. and Zhao, R.Y. (2005) Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res 15, 923-934.
105. Li, T., Santockyte, R., Yu, S., Shen, R.-F., Tekle, E., Lee, C.G.L., Yang, D.C.H. and Chock, P.B. (2011) FAT10 modifies p53 and upregulates its transcriptional activity. Arch. Biochem. Biophys. 509, 164-169.
106. Linares, L.K., Kiernan, R., Triboulet, R., Chable-Bessia, C., Latreille, D., Cuvier, O., Lacroix, M., Le Cam, L., Coux, O. and Benkirane, M. (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat. Cell Biol. 9, 331-338.
107. Liu, Y.C., Pan, J., Zhang, C., Fan, W., Collinge, M., Bender, J.R. and Weissman, S.M. (1999) A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci. U.S.A 96, 4313-4318.
108. Llano, M., Delgado, S., Vanegas, M. and Poeschla, E.M. (2004) Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279, 55570-55577.
109. Lukasiak, S., Schiller, C., Oehlschlaeger, P., Schmidtke, G., Krause, P., Legler, D.F., Autschbach, F., Schirmacher, P., Breuhahn, K. and Groettrup, M. (2008) Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27, 6068-6074.
110. Magadán, J.G., Pérez-Victoria, F.J., Sougrat, R., Ye, Y., Strebel, K. and Bonifacino, J.S. (2010) Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6, e1000869.
111. Majetschak, M. (2011) Extracellular ubiquitin: Immune modulator and endogenous opponent of damage-associated molecular pattern molecules. J. Leukoc. Biol. 89, 205-219.
112. Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J. and Piguet, V. (2009) HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5, e1000574.
113. Marchese, A. and Benovic, J.L. (2001) Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 276, 45509-45512.
114. Marchese, A., Raiborg, C., Santini, F., Keen, J.H., Stenmark, H. and Benovic, J.L. (2003) The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev. Cell 5, 709-722.
115. Margottin, F., Bour, S.P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K. and Benarous, R. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565-574.
116. Martin-Serrano, J. (2007) The role of ubiquitin in retroviral egress. Traffic 8, 1297-1303.
117. Martin-Serrano, J. and Bieniasz, P.D. (2003) A bipartite late-budding domain in human immunodeficiency virus type 1. J. Virol. 77, 12373-12377.
118. Martinez, N.W., Xue, X., Berro, R.G., Kreitzer, G. and Resh, M.D. (2008) Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 82, 9937-9950.
119. Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M. and Gabuzda, D. (2004) Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861-2866.
120. Merlet, J., Burger, J., Gomes, J.-E. and Pintard, L. (2009) Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization. Cell Mol. Life Sci. 66, 1924-1938.
121. Mettling, C., Desmetz, C., Fiser, A.-L., Réant, B., Corbeau, P. and Lin, Y.-L. (2008) Galphai protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription. AIDS 22, 1569-1576.
122. Milani, M., Rzymski, T., Mellor, H.R., Pike, L., Bottini, A., Generali, D. and Harris, A.L. (2009) The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 69, 4415-4423.
123. Mitchell, R.S., Katsura, C., Skasko, M.A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E.B., Margottin-Goguet, F., Benarous, R. and Guatelli, J.C. (2009) Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5, e1000450.
124. Miyagi, E., Andrew, A.J., Kao, S. and Strebel, K. (2009) Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U.S.A 106, 2868-2873.
125. Miyakawa, K., Ryo, A., Murakami, T., Ohba, K., Yamaoka, S., Fukuda, M., Guatelli, J. and Yamamoto, N. (2009) BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog. 5, e1000700.
126. Mizushima, N., Levine, B., Cuervo, A.M. and Klionsky, D.J. (2008) Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075.
127. Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M.D., Klionsky, D.J., Ohsumi, M. and Ohsumi, Y. (1998a) A protein conjugation system essential for autophagy. Nature 395, 395-398.
128. Mizushima, N., Sugita, H., Yoshimori, T. and Ohsumi, Y. (1998b) A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J. Biol. Chem. 273, 33889-33892.
129. Morita, E. and Sundquist, W.I. (2004) Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425.
130. Morita, E., Sandrin, V., McCullough, J., Katsuyama, A., Baci Hamilton, I. and Sundquist, W.I. (2011) ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9, 235-242.
131. Mousnier, A., Kubat, N., Massias-Simon, A., Ségéral, E., Rain, J.-C., Benarous, R., Emiliani, S. and Dargemont, C. (2007) von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc. Natl. Acad. Sci. U.S.A 104, 13615-13620.
132. Mukhopadhyay, D. and Dasso, M. (2007) Modification in reverse: The SUMO proteases. Trends Biochem. Sci. 32, 286-295.
133. Mulder, L.C. and Muesing, M.A. (2000) Degradation of HIV-1 integrase by the N-end rule pathway. J. Biol. Chem. 275, 29749-29753.
134. Mulder, L.C.F., Chakrabarti, L.A. and Muesing, M.A. (2002) Interaction of HIV-1 integrase with DNA repair protein hRad18. J. Biol. Chem. 277, 27489-27493.
135. Muriaux, D. and Darlix, J.-L. (2010) Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol. 7, 744-753.
136. Nagashima, Y., Kowa, H., Tsuji, S. and Iwata, A. (2011) FAT10 protein binds to polyglutamine proteins and modulates their solubility. J. Biol. Chem. 286, 29594-29600.
137. Nakayama, E.E. and Shioda, T. (2010) Anti-retroviral activity of TRIM5 alpha. Rev. Med. Virol. 20, 77-92.
138. Nelbock, P., Dillon, P.J., Perkins, A. and Rosen, C.A. (1990) A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248, 1650-1653.
139. Ocwieja, K.E., Brady, T.L., Ronen, K., Huegel, A., Roth, S.L., Schaller, T., James, L.C., Towers, G.J., Young, J.A.T., Chanda, S.K., König, R., Malani, N., Berry, C.C. and Bushman, F.D. (2011) HIV integration targeting: a pathway involving transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 7, e1001313.
140. Okumura, A., Alce, T., Lubyova, B., Ezelle, H., Strebel, K. and Pitha, P.M. (2008) HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373, 85-97.
141. Okumura, A., Lu, G., Pitha-Rowe, I. and Pitha, P.M. (2006) Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U.S.A 103, 1440-1445.
142. Ono, A. (2009) HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4, 241-257.
143. Ott, D.E., Coren, L.V., Chertova, E.N., Gagliardi, T.D. and Schubert, U. (2000) Ubiquitination of HIV-1 and MuLV Gag. Virology 278, 111-121.
144. Ozato, K., Shin, D.-M., Chang, T.-H. and Morse, H.C., 3rd (2008) TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8, 849-860.
145. Pandey, U.B., Nie, Z., Batlevi, Y., McCray, B.A., Ritson, G.P., Nedelsky, N.B., Schwartz, S.L., DiProspero, N.A., Knight, M.A., Schuldiner, O., Padmanabhan, R., Hild, M., Berry, D.L., Garza, D., Hubbert, C.C., Yao, T.-P., Baehrecke, E.H. and Taylor, J.P. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863.
146. Pardieu, C., Vigan, R., Wilson, S.J., Calvi, A., Zang, T., Bieniasz, P., Kellam, P., Towers, G.J. and Neil, S.J.D. (2010) The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 6, e1000843.
147. Peel, S., Macheboeuf, P., Martinelli, N. and Weissenhorn, W. (2011) Divergent pathways lead to ESCRT-III-catalyzed membrane fission. Trends Biochem. Sci. 36, 199-210.
148. Perron, M.J., Stremlau, M., Lee, M., Javanbakht, H., Song, B. and Sodroski, J. (2007) The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J. Virol. 81, 2138-2148.
149. Perry, J.J.P., Tainer, J.A. and Boddy, M.N. (2008) A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem. Sci. 33, 201-208.
150. Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F.A., Uchil, P.D., Chatel, L., Bisiaux, A., Albert, M.L., Strambio-De-Castillia, C., Mothes, W., Pizzato, M., Grütter, M.G. and Luban, J. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365.
151. Pierson, T.C. and Doms, R.W. (2003) HIV-1 entry and its inhibition. Curr. Top. Microbiol. Immunol. 281, 1-27.
152. Pincetic, A., Kuang, Z., Seo, E.J. and Leis, J. (2010) The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725-4736.
153. Poole, E., Strappe, P., Mok, H.-P., Hicks, R. and Lever, A.M.L. (2005) HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 6, 741-755.
154. Rabut, G. and Peter, M. (2008) Function and regulation of protein neddylation. "Protein modifications: Beyond the usual suspects" review series. EMBO Rep. 9, 969-976.
155. Remoli, A.L., Marsili, G., Perrotti, E., Gallerani, E., Ilari, R., Nappi, F., Cafaro, A., Ensoli, B., Gavioli, R. and Battistini, A. (2006) Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem. J. 396, 371-380.
156. Reyes-Turcu, F.E., Ventii, K.H. and Wilkinson, K.D. (2009) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397.
157. Robinson, P.A. and Ardley, H.C. (2004) Ubiquitin-protein ligases. J. Cell. Sci. 117, 5191-5194.
158. Roeth, J.F. and Collins, K.L. (2006) Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70, 548-563.
159. Roxrud, I., Stenmark, H. and Malerød, L. (2010) ESCRT & Co. Biol. Cell 102, 293-318.
160. Saini, V., Staren, D.M., Ziarek, J.J., Nashaat, Z.N., Campbell, E.M., Volkman, B.F., Marchese, A. and Majetschak, M. (2011) The CXC chemokine receptor 4 ligands ubiquitin and stromal-cell derived factor-1{alpha} function through distinct receptor interactions. J. Biol. Chem. 286, 33466-33477.
161. Sato, K., Yamamoto, S.P., Misawa, N., Yoshida, T., Miyazawa, T. and Koyanagi, Y. (2009) Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology 6, 53.
162. Sattentau, Q. (2008) Avoiding the void: Cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6, 815-826.
163. Schindler, M., Rajan, D., Banning, C., Wimmer, P., Koppensteiner, H., Iwanski, A., Specht, A., Sauter, D., Dobner, T. and Kirchhoff, F. (2010) Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 7, 1.
164. Schmid, D. and Münz, C. (2007) Innate and adaptive immunity through autophagy. Immunity 27, 11-21.
165. Schmidtke, G., Kalveram, B. and Groettrup, M. (2009) Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett. 583, 591-594.
166. Schneider-Schaulies, J., Schnorr, J.J., Brinckmann, U., Dunster, L.M., Baczko, K., Liebert, U.G., Schneider-Schaulies, S. and ter Meulen, V. (1995) Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. U.S.A 92, 3943-3947.
167. Schröfelbauer, B., Hakata, Y. and Landau, N.R. (2007) HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. U.S.A 104, 4130-4135.
168. Schröfelbauer, B., Yu, Q., Zeitlin, S.G. and Landau, N.R. (2005) Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J. Virol. 79, 10978-10987.
169. Schulman, B.A. and Harper, J.W. (2009) Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol. Cell Biol. 10, 319-331.
170. Schwartz, A.L. and Ciechanover, A. (2009) Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 49, 73-96.
171. Seeger, M., Ferrell, K., Frank, R. and Dubiel, W. (1997) HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. J. Biol. Chem. 272, 8145-8148.
172. Sette, P., Jadwin, J.A., Dussupt, V., Bello, N.F. and Bouamr, F. (2010) The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J. Virol. 84, 8181-8192.
173. Shibuya, H., Irie, K., Ninomiya-Tsuji, J., Goebl, M., Taniguchi, T. and Matsumoto, K. (1992) New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature 357, 700-702.
174. Shirakawa, K., Takaori-Kondo, A., Kobayashi, M., Tomonaga, M., Izumi, T., Fukunaga, K., Sasada, A., Abudu, A., Miyauchi, Y., Akari, H., Iwai, K. and Uchiyama, T. (2006) Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. Virology 344, 263-266.
175. Shirakawa, K., Takaori-Kondo, A., Yokoyama, M., Izumi, T., Matsui, M., Io, K., Sato, T., Sato, H. and Uchiyama, T. (2008) Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat. Struct. Mol. Biol 15, 1184-1191.
176. Simmons, A., Gangadharan, B., Hodges, A., Sharrocks, K., Prabhakar, S., García, A., Dwek, R., Zitzmann, N. and McMichael, A. (2005) Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling. Immunity 23, 621-634.
177. Skaug, B. and Chen, Z.J. (2010) Emerging role of ISG15 in antiviral immunity. Cell 143, 187-190.
178. Snyder, A., Alsauskas, Z., Gong, P., Rosenstiel, P.E., Klotman, M.E., Klotman, P.E. and Ross, M.J. (2009) FAT10: A novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy. J. Virol. 83, 11983-11988.
179. Strack, B., Calistri, A., Craig, S., Popova, E. and Göttlinger, H.G. (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689-699.
180. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D.J., Sundquist, W.I. and Sodroski, J. (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A 103, 5514-5519.
181. Sugiyama, R., Nishitsuji, H., Furukawa, A., Katahira, M., Habu, Y., Takeuchi, H., Ryo, A. and Takaku, H. (2011) Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G. J. Biol. Chem. 286, 10051-10057.
182. Sundquist, W.I., Schubert, H.L., Kelly, B.N., Hill, G.C., Holton, J.M. and Hill, C.P. (2004) Ubiquitin recognition by the human TSG101 protein. Mol. Cell 13, 783-789.
183. Swanson, C.M. and Malim, M.H. (2006) Retrovirus RNA trafficking: From chromatin to invasive genomes. Traffic 7, 1440-1450.
184. Swanson, C.M., Puffer, B.A., Ahmad, K.M., Doms, R.W. and Malim, M.H. (2004) Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J. 23, 2632-2640.
185. Tang, Y., Zhong, G., Zhu, L., Liu, X., Shan, Y., Feng, H., Bu, Z., Chen, H. and Wang, C. (2010) Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184, 5777-5790.
186. Usami, Y., Popov, S., Popova, E. and Göttlinger, H.G. (2008) Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J. Virol. 82, 4898-4907.
187. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R.L., Mitchell, R., Johnson, M.C., Stephens, E.B. and Guatelli, J. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252.
188. Van Maele, B. and Debyser, Z. (2005) HIV-1 integration: An interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev 7, 26-43.
189. van Wijk, S.J.L. and Timmers, H.T.M. (2010) The family of ubiquitin-conjugating enzymes (E2s): Deciding between life and death of proteins. FASEB J. 24, 981-993.
190. VerPlank, L., Bouamr, F., LaGrassa, T.J., Agresta, B., Kikonyogo, A., Leis, J. and Carter, C.A. (2001) Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U.S.A 98, 7724-7729.
191. Votteler, J., Iavnilovitch, E., Fingrut, O., Shemesh, V., Taglicht, D., Erez, O., Sörgel, S., Walther, T., Bannert, N., Schubert, U. and Reiss, Y. (2009) Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release. BMC Biochem. 10, 12.
192. Wang, L., Mukherjee, S., Jia, F., Narayan, O. and Zhao, L.J. (1995) Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569.
193. Weidberg, H., Shvets, E., Shpilka, T., Shimron, F., Shinder, V. and Elazar, Z. (2010) LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 29, 1792-1802.
194. Weiss, E.R., Popova, E., Yamanaka, H., Kim, H.C., Huibregtse, J.M. and Göttlinger, H. (2010) Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog. 6, e1001107.
195. Welsch, S., Keppler, O.T., Habermann, A., Allespach, I., Krijnse-Locker, J. and Kräusslich, H.-G. (2007) HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36.
196. Wilkinson, K.A. and Henley, J.M. (2010) Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428, 133-145.
197. Williams, R.L. and Urbé, S. (2007) The emerging shape of the ESCRT machinery. Nat. Rev. Mol. Cell Biol. 8, 355-368.
198. Wong, J.J.Y., Pung, Y.F., Sze, N.S.-K. and Chin, K.-C. (2006) HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc. Natl. Acad. Sci. U.S.A. 103, 10735-10740.
199. Wright, M.H., Berlin, I. and Nash, P.D. (2011) Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination. Cell Biochem. Biophys. 60, 39-46.
200. Wu, C.-Y., Jeng, K.-S. and Lai, M.M.-C. (2011) The SUMOylation of matrix M1 protein modulates the assembly and morphogenesis of influenza A virus. J. Virol. 85, 6618-6628.
201. Wu, Y.-C., Roark, A.A., Bian, X.-L. and Wilson, V.G. (2008) Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology 378, 329-338.
202. Xirodimas, D.P. (2008) Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem. Soc. Trans. 36, 802-806.
203. Yamamoto, S.P., Okawa, K., Nakano, T., Sano, K., Ogawa, K., Masuda, T., Morikawa, Y., Koyanagi, Y. and Suzuki, Y. (2011) Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity. Microbes Infect. 13, 339-349.
204. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P. and Yu, X.-F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
205. Yu, Y., Xiao, Z., Ehrlich, E.S., Yu, X. and Yu, X.-F. (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 18, 2867-2872.
206. Zaitseva, M., Romantseva, T., Manischewitz, J., Wang, J., Goucher, D. and Golding, H. (2005) Increased CXCR4-dependent HIV-1 fusion in activated T cells: Role of CD4/CXCR4 association. J. Leukoc. Biol. 78, 1306-1317.
207. Zamborlini, A., Coiffic, A., Beauclair, G., Delelis, O., Paris, J., Koh, Y., Magne, F., Giron, M.-L., Tobaly-Tapiero, J., Deprez, E., Emiliani, S., Engelman, A., de The, H. and Saib, A. (2011) Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect. J. Biol. Chem. 286, 21013-20122.
208. Zhang, D. and Zhang, D.-E. (2011) Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 31, 119-130.
209. Zhang, W., Huang, M., Wang, T., Tan, L., Tian, C., Yu, X., Kong, W. and Yu, X.-F. (2008) Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases. Cell. Microbiol. 10, 1662-1675.
210. Zheng, Y., Ao, Z., Wang, B., Danappa Jayappa, K. and Yao, X. (2011) Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication. J. Biol. Chem. 286, 17722-17735.
211. Zou, W. and Zhang, D.-E. (2006) The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281, 3989-3994.